title: Endocannabinoids in synaptic plasticity and neuroprotection.
abstract: Endocannabinoids (eCBs) are endogenous lipid mediators involved in a variety of physiological, pharmacological, and pathological processes. While activation of the eCB system primarily induces inhibitory effects on both GABAergic and glutamatergic synaptic transmission and plasticity through acting on presynaptically expressed CB1 receptors in the brain, accumulated information suggests that eCB signaling is also capable of facilitating or potentiating excitatory synaptic transmission in the hippocampus. Recent studies show that a long-lasting potentiation of excitatory synaptic transmission at Schaffer collateral (SC)-CA1 synapses is induced by spatiotemporally primed inputs, accompanying with a long-term depression of inhibitory synaptic transmission (I-LTD) in hippocampal CA1 pyramidal neurons. This input timing-dependent long-lasting synaptic potentiation at SC-CA1 synapses is mediated by 2-arachidonoylglycerol (2-AG) signaling triggered by activation of postsynaptic N-methyl-D-aspartate receptors, group I metabotropic glutamate receptors (mGluRs), and a concurrent rise in intracellular Ca(2+). Emerging evidence now also indicates that 2-AG is an important signaling mediator keeping brain homeostasis by exerting its anti-inflammatory and neuroprotective effects in response to harmful insults through CB1/2 receptor-dependent and/or -independent mechanisms. Activation of the nuclear receptor protein peroxisome proliferator-activated receptor-γ apparently is one of the important mechanisms in resolving neuroinflammation and protecting neurons produced by 2-AG signaling. Thus, the information summarized in this review suggests that the role of eCB signaling in maintaining integrity of brain function is greater than what we thought previously.
authors.affiliation: CancerControl Alberta, Alberta Health Services, Calgary, Alberta, Canada.
authors.forename: Jian-Yi
authors.initials: JY
authors.lastname: Xu
authors.affiliation: Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA jianyi.xu@albertahealthservices.ca chen502@gmail.com.
authors.forename: Chu
authors.initials: C
authors.lastname: Chen
mesh_terms: D000818:Animals; D001921:Brain / Q000502:physiology*; D001927:Brain Diseases / Q000503:physiopathology; D063388:Endocannabinoids / Q000502:physiology*; D006624:Hippocampus / Q000502:physiology; D006801:Humans; D009473:Neuronal Plasticity; D000066829:Neuroprotection; D017966:Pyramidal Cells / Q000502:physiology; D015398:Signal Transduction
chemical_list: D063388:Endocannabinoids
keywords: Alzheimer’s disease; PPARγ; chronic traumatic encephalopathy; input timing–dependent plasticity; long-term depression of inhibitory synaptic transmission; monoacylglycerol lipase